SITS (Safe Implementation of Treatments in Stroke) Open Artery by Thrombectomy in Acute Occlusive Stroke Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 341 participants.

Also called NCT02326428

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 341 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02326428
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02326428. Non-randomized; single masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2018-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SITS (Safe Implementation of Treatments in Stroke) Open Artery by Thrombectomy in Acute Occlusive Stroke Study
Acronym
SITS Open
Intervention (Device)
Stent retriever endovascular device for thrombectomy
Intervention (Drug)
Intravenous thrombolysis by alteplase (Actilyse) (optional)
Lead sponsor
Karolinska Institutet (class: other)
Collaborator
Swedish Heart Lung Foundation (class: other)
Collaborator
Medtronic - MITG (class: industry)
Collaborator
Stryker Nordic (class: industry)
Collaborator
Phenox GmbH (class: industry)

Record details

Record id
cardio:ct-nct02326428
Content hash
a175d3f827617ecaac8f8c295f25d679bb3afa3b3fbd9c1e45210ac2605b97e8